Company Profile
Pacific Biosciences Stock Price, News & Catalysts
- Ticker:
- PACB
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.21 USD (+5.22%)
Close
Last updated: August 17, 2026
491M USD
Market cap
Why the stock is moving
As of Aug 17, 2026, PACB closed up 5.22% at $1.21. No new same-company headline was identified in the current news window.
Company overview
Long-Read Sequencing
Pacific Biosciences, or PacBio, develops high-accuracy long-read sequencing systems used in research and clinical genomics. Its HiFi technology reads long DNA fragments while maintaining high base-level accuracy.
Sequencing Platforms
The company's instrument portfolio includes high-throughput Revio systems and benchtop Vega systems. Revenue combines instrument placements with recurring consumables, service and software. PacBio technology is used for whole-genome sequencing, rare-disease analysis, population genomics, microbial research and other applications where resolving structural variation and complex genomic regions is important.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Pacific Biosciences (PACB)?
Pacific Biosciences (PACB) most recently closed at 1.21 USD, a +5.22% move versus the previous session.
What is the market cap of Pacific Biosciences (PACB)?
Pacific Biosciences currently has a market capitalization of 491M USD on BioPharmSignal.
What does Pacific Biosciences do?
Long-Read Sequencing Pacific Biosciences, or PacBio, develops high-accuracy long-read sequencing systems used in research and clinical genomics. Its HiFi technology reads long DNA fragments while maintaining high base-level accuracy. Sequencing Platforms The company's instrument portfolio includes high-throughput Revio systems and benchtop Vega systems....
On which exchange is PACB stock listed?
Pacific Biosciences (PACB) is associated with NASDAQ, United States, Biopharma.
What is Long-Read?
Long-Read Sequencing Pacific Biosciences, or PacBio, develops high-accuracy long-read sequencing systems used in research and clinical genomics.
Which conditions is Pacific Biosciences targeting with Long-Read?
Long-Read Sequencing Pacific Biosciences, or PacBio, develops high-accuracy long-read sequencing systems used in research and clinical genomics. Its HiFi technology reads long DNA fragments while maintaining high base-level accuracy. Sequencing Platforms The company's instrument portfolio includes high-throughput Revio systems and benchtop Vega systems....
What is Sequencing?
Long-Read Sequencing Pacific Biosciences, or PacBio, develops high-accuracy long-read sequencing systems used in research and clinical genomics.
What is Pacific?
Long-Read Sequencing Pacific Biosciences, or PacBio, develops high-accuracy long-read sequencing systems used in research and clinical genomics.